Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy

被引：0
|
作者：
Chen, P. -W. [1 ]
Ho, M. -Y. [2 ]
Feng, W. -H. [3 ]
Su, C. -H. [4 ]
Huang, S. -W. [4 ]
Cheng, C. -W. [5 ]
Yeh, H. -I. [5 ]
Chen, C. -P. [6 ]
Huang, W. -C. [7 ]
Fang, C. -C. [8 ]
Lin, H. -W. [1 ]
Lin, S. -H. [1 ]
Hsieh, I. -C. [2 ]
Li, Y. -H. [1 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, taoyuan, Taiwan
[3] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
[4] Chung Shan Med Univ Hosp, Taichung, Taiwan
[5] Mackay Mem Hosp, Taipei, Taiwan
[6] Changhua Christian Hosp, Changhua, Taiwan
[7] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan
[8] Tainan Municipal Hosp, Tainan, Taiwan
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1208 / 1208
页数：1
相关论文
共 50 条
  • [21] P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Chen, Po-Wei
    Feng, Wen-Han
    Ho, Ming-Yun
    Su, Chun-Hung
    Huang, Sheng-Wei
    Cheng, Chung-Wei
    Yeh, Hung-, I
    Chen, Ching-Pei
    Huang, Wei-Chun
    Fang, Ching-Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Hsieh, I-Chang
    Li, Yi-Heng
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [22] Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?
    Chandiramani, Rishi
    Mehta, Adhya
    Blumenthal, Roger S.
    Williams, Marlene S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (11) : 649 - 658
  • [23] P2Y12 Inhibitor Monotherapy Is Superior to Aspirin Monotherapy in Chronic Limb-Threatening Ischemia Postendovascular Intervention
    Fakhoury, Elias
    Khan, Sikandar
    O'Brien-Irr, Monica
    Dosluoglu, Hasan H.
    Harris, Linda
    Rivero, Mariel
    Cherr, Gregory
    Dryjski, Maciej
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E248 - E248
  • [24] Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out!
    Grines, Cindy L.
    Marshall, J. Jeffrey
    EUROPEAN HEART JOURNAL, 2019, 40 (31) : 2605 - 2606
  • [25] Optimizing Monotherapy Selection, Aspirin Versus P2Y12 Inhibitors, Following Percutaneous Coronary Intervention
    Yerasi, Charan
    Case, Brian C.
    Forrestal, Brian J.
    Torguson, Rebecca
    Weintraub, William S.
    Garcia-Garcia, Hector M.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 135 : 154 - 165
  • [26] P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
    Capodanno, Davide
    Baber, Usman
    Bhatt, Deepak L.
    Collet, Jean-Philippe
    Dangas, George
    Franchi, Francesco
    Gibson, C. Michael
    Gwon, Hyeon-Cheol
    Kastrati, Adnan
    Kimura, Takeshi
    Lemos, Pedro A.
    Lopes, Renato D.
    Mehran, Roxana
    O'Donoghue, Michelle L.
    Rao, Sunil, V
    Rollini, Fabiana
    Serruys, Patrick W.
    Steg, Philippe G.
    Storey, Robert F.
    Valgimigli, Marco
    Vranckx, Pascal
    Watanabe, Hirotoshi
    Windecker, Stephan
    Angiolillo, Dominick J.
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (12) : 829 - 844
  • [27] Sex-related bleeding risk in acute coronary syndrome patients receiving dual antiplatelet therapy with aspirin and a P2Y12 inhibitor.
    ten Haaf, Monique E. E.
    van Geuns, Robert-Jan M.
    van der Linden, Marc M. J. M.
    Smits, Pieter C. C.
    de Vries, Arie G. G.
    Doevendans, Pieter A. A.
    Appelman, Yolande
    Boersma, Eric
    MEDICAL PRINCIPLES AND PRACTICE, 2023, 32 (03) : 200 - 208
  • [28] P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
    Davide Capodanno
    Usman Baber
    Deepak L. Bhatt
    Jean-Philippe Collet
    George Dangas
    Francesco Franchi
    C. Michael Gibson
    Hyeon-Cheol Gwon
    Adnan Kastrati
    Takeshi Kimura
    Pedro A. Lemos
    Renato D. Lopes
    Roxana Mehran
    Michelle L. O’Donoghue
    Sunil V. Rao
    Fabiana Rollini
    Patrick W. Serruys
    Philippe G. Steg
    Robert F. Storey
    Marco Valgimigli
    Pascal Vranckx
    Hirotoshi Watanabe
    Stephan Windecker
    Dominick J. Angiolillo
    Nature Reviews Cardiology, 2022, 19 : 829 - 844
  • [29] P2Y12 Inhibitor Monotherapy Versus Conventional Dual Antiplatelet Therapy or Aspirin Monotherapy in Acute Coronary Syndrome: A Pooled Analysis of the SMART-DATE and SMART-CHOICE Trials
    Song, Pil Sang
    Park, Yong Hwan
    Oh, Ju-Hyeon
    Song, Young Bin
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Cho, Deok-Kyu
    Rha, Seung-Woon
    Bae, Jang-Whan
    Jeong, Jin-Ok
    Hahn, Joo-Yong
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 150 : 47 - 54
  • [30] EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION
    Harris, Daniel
    Lacey, Arron
    Akbari, Ashley
    Gravenor, Mike B.
    Halcox, Julian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 74 - 74
12345